Mindbio Therapeutics Stock Price, News & Analysis
Company Description
Mindbio Therapeutics (OTC Link: MBQIF) is a publicly traded company.
MBQIF stock has declined 13.9% over the past year. Shares last traded at $0.6800.
This page provides a comprehensive overview of MBQIF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Mindbio Therapeutics (MBQIF) stock last traded at $0.6800. Over the past 12 months, the stock has lost 13.9%.
Latest News
Mindbio Therapeutics has 2 recent news articles, with the latest published 5 days ago. Of the recent coverage, 0 articles coincided with positive price movement and 1 with negative movement. Key topics include AI. View all MBQIF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Mindbio Therapeutics (MBQIF) currently stands at 717 shares, down 7.4% from the previous reporting period, representing 0.0% of the float. Over the past 12 months, short interest has increased by 35.3%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Mindbio Therapeutics (MBQIF) currently stands at 2.7 days, up 172% from the previous period. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The days to cover has increased 172% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 2.7 days.